Integrated Whole‐Genome and RNA Sequencing Analysis of FFPE Lung Cancer Samples: Feasibility and Pathological Validation
Pathology International · 2026-11 · 76 (11)
DOI: 10.1111/pin.70199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, online erschienen am 01.11.2026. Verfasst von Shinichiro Kiyose und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Whole Genome Sequencing, Sequence Analysis, RNA, Adenocarcinoma of Lung. Die Arbeit nennt 17 Literaturangaben. Gefördert von: JOKOH Co. Ltd.
Abstract (Originalsprache)
Whole‐genome sequencing (WGS) and RNA sequencing (RNA‐seq) can be applied to formalin‐fixed paraffin‐embedded (FFPE) specimens for genomic and transcriptomic analyses, including gene rearrangement detection. We tested whether PCR‐free WGS and RNA‐seq could detect driver alterations in FFPE lung adenocarcinoma samples prepared under standardized automated fixation and embedding conditions. Two adenocarcinoma cases were analyzed. Before this study, immunohistochemistry had suggested an EGFR alteration in one case and an ALK alteration in the other, although neither had been confirmed at the genomic or chromosomal level. In this analysis, PCR‐free WGS yielded stable sequencing metrics and successfully detected small variants, including the canonical EGFR p.Leu858Arg mutation. By contrast, conventional structural variant calling failed to identify the EML4 :: ALK rearrangement. However, a custom algorithm based on supplementary alignment tags recovered the fusion candidate from WGS data despite support from only a single junction read, and RNA‐seq independently confirmed expression of the EML4::ALK fusion transcript. Break‐apart fluorescence in situ hybridization demonstrated tumor‐wide clonal ALK rearrangement. These findings show that a single junction read can be biologically meaningful only when supported by orthogonal pathological validation and highlight the importance of integrating sequencing findings with pathological validation for the interpretation of gene rearrangements in FFPE specimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- JOKOH Co. Ltd., Kawasaki, Japan.
- Department of Pathology, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
- Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
ORCID-Profile: Kazuya Shinmura
Förderung
- JOKOH Co. Ltd
Zitieren
APA
Kiyose, S., Yamada, H., Miyazaki, R., Yoshimura, K., Takeuchi, S., Takahashi, S., Tanahashi, M., Konno, K., Hoshino, H., Hoshi, G., Ozawa, H., Chiba, H., Hattori, N., & Shinmura, K. (2026). Integrated Whole‐Genome and RNA Sequencing Analysis of FFPE Lung Cancer Samples: Feasibility and Pathological Validation. Pathology International, 76(11). https://doi.org/10.1111/pin.70199
Vancouver
Kiyose S, Yamada H, Miyazaki R, Yoshimura K, Takeuchi S, Takahashi S, et al. Integrated Whole‐Genome and RNA Sequencing Analysis of FFPE Lung Cancer Samples: Feasibility and Pathological Validation. Pathology International. 2026;76(11). doi:10.1111/pin.70199
BibTeX
@article{Kiyose2026,
author = {Kiyose, Shinichiro and Yamada, Hidetaka and Miyazaki, Ryosuke and Yoshimura, Katsuhiro and Takeuchi, Sayuri and Takahashi, Seishiro and Tanahashi, Masayuki and Konno, Keisuke and Hoshino, Hideaki and Hoshi, Genki and Ozawa, Hinako and Chiba, Hironori and Hattori, Naohiko and Shinmura, Kazuya},
title = {Integrated Whole‐Genome and RNA Sequencing Analysis of FFPE Lung Cancer Samples: Feasibility and Pathological Validation},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {11},
doi = {10.1111/pin.70199}
}
EUVIMED